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Dr. Robert Langer a professor of chemical and 
biomedical engineering at Massachusetts Institute of 
Technology once stated that the need for novel 
material can generally be broken into two categories, 
the creation of new materials and manipulation of the 
existing materials. In both cases the current needs of 
the novel therapeutics include reducing the toxicity of 
materials, optimizing the pharmacokinetic 
parameters, and finally increasing their concentration 
at the desired target. These physiochemical properties 
are considered ideal for any pharmaceuticals. Even 
though the task is daunting, researchers across the 
world have accepted this challenge and seek to 
develop ideal pharmaceuticals by excavating nature 
and developing new materials. Polymers are one such 
class of materials that has been developed in the 
search of better pharmaceuticals. The application of 
the polymeric materials for medical purposes is 
growing fast. Polymers have found applications in 
diverse biomedical fields such as drug delivering 
systems, developing scaffolds in tissue engineering, 
implantation of medical devices and artificial organs, 
prosthesis, ophthalmology, dentistry, bone repair, and 
many other medical fields.  
For almost four decades, both natural and synthetic 
polymers have been investigated for use as carriers 
for controlling drug dosage. This coalition of 
polymeric science with the pharmaceutical science 
led to the innovation in the design and the 
development of novel drug delivering systems. The 
purpose of the polymers in such system is to deliver 
drugs to target pathological cells in order to increase 
the effectiveness of drugs thus reducing their 
undesirable side effects. Besides, the polymer core 
also protects the drugs from the physiological 
environment in vivo and thus increases the 
bioavailability of the drug to the patients. Hence, the 
polymeric drug delivering systems offer some 
unambiguous advantages such as localized and 
sustained delivery of the drug. This becomes 
especially important for toxic drugs which are related 
to various systemic side effects.  In addition, for 
polymers to be used as drug carriers, they should 
have a well defined structure, should be 
biocompatible and non toxic. This led to invention of 
novel polymers with desired physiochemical 
properties to exploit them in drug delivery systems. 
Due to these superlative properties of polymers 
various drug delivering systems such as 
biodegradable drug delivery systems, diffusion 
controlled drug delivering systems, and responsive 
drug delivery systems have been developed over the 
period of years. These unique polymeric delivering 
systems are differentiated on the basis of the 
mechanism controlling release of the drug from the 
polymers.  
Amongst, these novel classes of the polymeric 
delivering systems the biodegradable delivering 
system is most commonly favored to target specific 
areas of the body such as inflammation or tumors. In 
fact, the synthetic conjugates of biodegradable poly-
3-hydroxybutrate are currently been investigated for 
the delivery of non steroidal anti-inflammatory agents 
such as aspirin, ibuprofen, ketoprofen, naproxen, and 
diclofenac for treating inflammations. These 
biodegradable polymers disintegrate into 
biocompatible compounds when exposed to 
chemicals (water), enzymes, or microbial which 
subsequently leave their incorporated medications 
behind. The drug molecule present in the system is 
released due to this process of erosion either in bulk 
or at the polymer’s surface. The degradation process 
basically involves the breakdown of polymers which 
are then further reduced by the Kreb’s cycle to carbon 
dioxide and water. Furthermore, the biodegradability 
of these polymers can be easily manipulated by 
incorporating a variety of labile groups such as ester, 
orthoester, anhydride, carbonate, amide, urea, and 
urethane in their backbone. Examples of such 
polymers include polyanhydrides, polyesters, 
polyacrylic acids, poly (methyl methacrylates), and 
polyurethanes. Mody / Introduction of Polymeric Drug Delivery 
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Correspondingly, diffusion controlled drug delivering 
systems involve the dispersion of therapeutic agent 
within a polymer shell such as macromolecules. The 
sustained release of therapeutic agents by this system 
is driven by diffusion and the drug is released either 
by passing through the pores or between polymer 
chains. These are the processes that control the 
release rate. The ease of preparation and the 
commercial success of intra-uterine contraceptives 
such as Progestasert®, Norplant®, and various 
transdermal patches such as Nicoderm®, and 
Transderm Nitro® have triggered intense research in 
this field. 
Responsive drug delivery systems are another class 
of delivery systems where the rate of drug released 
can be controlled by its surrounding such as, 
temperature, solvent, pH, or concentration.  Poly (N-
isopropylacrylamide) is a well-known example of a 
thermo-responsive polymer which exhibits lower 
critical solution temperature or phase separation at 
about 32
oC. This polymer is soluble in water; but, as 
temperature is increased, the polymer precipitates and 
phase separates.  Similarly, copolymers of poly 
(ethylene glycol) and poly (propylene glycol) and the 
copolymers of poly (lactic acid) and poly (glycolic 
acid) copolymers also exhibit thermo-responsiveness. 
These copolymers are useful in developing 
thermogelling systems which are liquid at low 
temperature and gel at human body temperature 
(37°C) which eventually degrades and releases the 
drug molecules.  The gels such as Atridox® are 
injected or applied to specific local sites and offer 
therapeutic properties for the local repair of damaged 
tissue such as cartilage, bone and chronic wounds. 
The unique ability of these responsive systems to gel 
at body temperature offers the key benefit.  
Thus, cosmic advances have been made in the field of 
polymeric drug delivery and the delivery systems 
described here represents a mere latent image of what 
has been developed so far. Even though, few of these 
delivery systems even extend beyond the domain of 
laboratory and has found applications in other 
processes including aerosol inhalation devices, 
forced-pressure injectables, and gene therapies. The 
research into drug delivery systems extends beyond 
traditional pharmaceuticals to achieve therapeutic 
effects in humans so that the safety and efficacy of 
current treatments may be improved. Moreover, this 
novel therapeutics can be easily managed if their 
delivery rate, biodegradation, and site-specific 
targeting can be predicted, monitored, and controlled. 
This will not only be beneficial from a global health 
care perspective, but also play a constructive role in 
reducing cost of traditional time consuming long term 
treatments. 
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